The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data

Authors:
  • JLJieli Lu
    Jieli Lu
  • JQJiying Qi
    Jiying Qi
  • HLHaoyu Liu
    Haoyu Liu
  • ZCZhihe Chen
    Zhihe Chen
  • LHLanhui Huang
    Lanhui Huang
  • MXMin Xu
    Min Xu
  • YXYu Xu
    Yu Xu
  • TWTiange Wang
    Tiange Wang

Abstract
No abstract available
Funding Information
  • Innovative Research Team of High-level Local University in Shanghai
  • Cancer Research UK (C18281/A29019)
  • Shanghai Shenkang Hospital Development Center (SHDC12019101, SHDC2020CR3064B, SHDC2020CR1001A)
  • National Institute for Health and Care Research (NIHR202411, 15825)
  • Medical Research Council (MC_UU_00032/03)
  • National Key Research and Development Program of China (2022YFC2505203)
  • University of Bristol
  • Wellcome Trust
  • British Heart Foundation
  • Diabetes UK
  • NIHR Bristol Biomedical Research Centre
  • National Natural Science Foundation of China (82170819, 82370810, 82088102, 81970728, 81941017, 81970691, 81930021)
  • Department for Business, Energy and Industrial Strategy, UK Government
  • Academy of Medical Sciences
  • University Hospitals Bristol NHS Foundation Trust (C68933/A28534)

This publication has 63 references indexed in Scilit: